Ep 10 - Healthcare in the UK (Oct 28, 2024)

In episode 10 of Hims House, Jonathan Stern, Louis Stevens, and Dr. H interview Sekander Amini, a UK-based pharmacist and long-time Hims investor. Sekander shares insights about how his pharmacy mirrors Hims' model by offering premium services like mental health and weight loss medications. He highlights Hims' advantages in compounding medications, simplifying treatment adherence, and leveraging technology for better patient care. The group discusses the healthcare landscape in the UK, touching on public versus private care and the potential growth opportunity for Hims. They also explore Hims' focus on premium experiences, the role of AI in healthcare, and what investors should watch for in the upcoming earnings call.00:00 Introduction and Sekander Amino Welcome00:52 Day-to-Day at the Private Pharmacy03:24 Initial Investment in Hims03:51 Hims' Price Transparency and Accessibility05:46 Compounded Medications and Personalized Care07:07 Premium Experience and Product Evolution15:59 Comparing UK and US Healthcare Systems20:53 Opportunities in the UK Market23:09 Hims' Generic Offerings23:30 UK Healthcare System Overview24:19 Hims' Market Potential in the UK24:48 Compounding Pharmacies in the UK25:40 Challenges in International Expansion27:10 Hims' Strategic Focus34:18 MedMatch and Mental Health40:14 International Expansion Concerns44:09 Q3 Earnings Expectations45:54 Closing Remarks and Farewell Get full access to Hims House at himshouse.substack.com/subscribe